Redesign of Glycopeptide Antibiotics: Back to the Future
- 13 February 2012
- journal article
- perspective
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 7 (5), 797-804
- https://doi.org/10.1021/cb300007j
Abstract
The glycopeptide antibiotics are the most important class of drugs used in the treatment of resistant bacterial infections including those caused by methicillin-resistant Staphylococcus aureus (MRSA). After more than 50 years of clinical use, the emergence of glycopeptide-resistant Gram-positive pathogens such as vancomycin-resistant enterococci (VRE) and vancomycin-resistant Staphylococcus aureus (VRSA) presents a serious global challenge to public health at a time few new antibiotics are being developed. This has led to renewed interest in the search for additional effective treatments including the development of new derivatives of the glycopeptide antibiotics. General approaches have been explored for modifying glycopeptide antibiotics, typically through the derivatization of the natural products themselves or more recently through chemical total synthesis. In this Perspective, we consider recent efforts to redesign glycopeptide antibiotics for the treatment of resistant microbial infections, including VRE and VRSA, and examine their future potential for providing an even more powerful class of antibiotics that are even less prone to bacterial resistance.Keywords
This publication has 43 references indexed in Scilit:
- Total Synthesis of [Ψ[C(═S)NH]Tpg4]Vancomycin Aglycon, [Ψ[C(═NH)NH]Tpg4]Vancomycin Aglycon, and Related Key Compounds: Reengineering Vancomycin for Dual d-Ala-d-Ala and d-Ala-d-Lac BindingJournal of the American Chemical Society, 2011
- Synthesis and Stereochemical Determination of Complestatin A and B (Neuroprotectin A and B)Journal of the American Chemical Society, 2011
- A Redesigned Vancomycin Engineered for Dual d-Ala-d-Ala and d-Ala-d-Lac Binding Exhibits Potent Antimicrobial Activity Against Vancomycin-Resistant BacteriaJournal of the American Chemical Society, 2011
- Dissemination of an Enterococcus Inc18-Like vanA Plasmid Associated with Vancomycin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2010
- Total Synthesis of Complestatin: Development of a Pd(0)-Mediated Indole Annulation for MacrocyclizationJournal of the American Chemical Society, 2010
- Reduced Vancomycin Susceptibility inStaphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical ImplicationsClinical Microbiology Reviews, 2010
- TelavancinNature Reviews Drug Discovery, 2009
- Total Synthesis of Chloropeptin II (Complestatin) and Chloropeptin IJournal of the American Chemical Society, 2009
- Chemistry and Biology of Ramoplanin: A Lipoglycodepsipeptide with Potent Antibiotic ActivityChemical Reviews, 2005
- Total synthesis of azafluoranthene alkaloids: rufescine and imeluteineThe Journal of Organic Chemistry, 1984